US Stock MarketDetailed Quotes

Processa Pharmaceuticals (PCSA)

Watchlist
  • 3.710
  • +0.250+7.23%
Close Jan 15 15:57 ET
  • 3.700
  • -0.010-0.27%
Post 20:01 ET
8.41MMarket Cap-0.13P/E (TTM)

Processa Pharmaceuticals (PCSA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.28%-3.48M
32.14%-2.27M
-33.24%-2.73M
-39.46%-11.25M
-5.83%-2.25M
-104.58%-3.6M
-62.07%-3.35M
3.08%-2.05M
16.05%-8.06M
14.96%-2.12M
Net income from continuing operations
-1.53%-3.44M
-30.68%-3.93M
-3.96%-2.83M
-6.55%-11.85M
-13.46%-2.73M
-62.57%-3.38M
-15.22%-3.01M
32.21%-2.73M
59.45%-11.12M
81.52%-2.4M
Depreciation and amortization
48.28%301
116.55%301
116.55%301
252.25%782
115.00%301
147.56%203
--139
--139
-99.97%222
-99.93%140
Other non cash items
10.39%24.32K
9.96%23.42K
7.34%22.94K
-93.74%87.18K
7.18%22.48K
7.10%22.03K
5.53%21.3K
-98.39%21.37K
256.91%1.39M
-63.13%20.98K
Change In working capital
4.79%-375.46K
381.91%1.44M
-129.98%-146.4K
-118.57%-112.4K
9,594.72%303.15K
-350.42%-394.33K
-344.06%-509.57K
107.08%488.34K
11.33%605.21K
-98.55%3.13K
-Change in receivables
--0
24.58%27.77K
-24.36%-27.77K
-225.00%-39
--0
--0
--22.3K
---22.33K
-100.02%-12
----
-Change in prepaid assets
-39.64%-55.61K
158.69%615.84K
89.32%130K
-207.69%-1.03M
-108.35%-10.06K
-122.97%-39.82K
-507.67%-1.05M
-83.07%68.67K
354.45%956.83K
236.11%120.49K
-Change in payables and accrued expense
10.76%-298.02K
51.76%815.69K
-148.87%-226.3K
467.31%1M
469.67%335.09K
-16,690.35%-333.96K
1,936.28%537.5K
407.06%463.1K
-177.38%-272.72K
-128.05%-90.64K
-Change in other current liabilities
-6.25%-21.83K
-12.99%-22.76K
-5.83%-22.31K
-6.02%-83.65K
-4.32%-21.87K
-4.33%-20.55K
-4.34%-20.15K
-11.40%-21.08K
10.28%-78.9K
-13.23%-20.97K
-Change in other working capital
----
----
----
----
----
--0
--22.3K
-43,692.16%-22.33K
----
----
Cash from discontinued investing activities
Operating cash flow
3.28%-3.48M
32.14%-2.27M
-33.24%-2.73M
-39.46%-11.25M
-5.83%-2.25M
-104.58%-3.6M
-62.07%-3.35M
3.08%-2.05M
16.05%-8.06M
14.96%-2.12M
Investing cash flow
Cash flow from continuing investing activities
-16.86%-3.24K
0
-2.78K
0
Net PPE purchase and sale
----
----
----
-16.86%-3.24K
--0
----
----
----
---2.78K
--0
Cash from discontinued investing activities
Investing cash flow
----
----
----
-16.86%-3.24K
--0
----
----
----
---2.78K
--0
Financing cash flow
Cash flow from continuing financing activities
208.38%2.86M
184,925.81%6.31M
-29.18%4.44M
23.37%7.73M
1,889.07%547.58K
1,855.95%926.2K
-3.41K
-1.40%6.26M
1,712.15%6.27M
42.89%-30.61K
Net issuance payments of debt
-161.10%-3.75K
6.54%-1.31K
-71.62%-1.54K
---5.2K
---1.46K
---1.44K
---1.41K
---895
--0
--0
Net common stock issuance
208.30%2.86M
314,406.13%6.31M
-29.26%4.44M
22.55%7.75M
1,893.86%549.05K
--927.63K
---2.01K
-1.25%6.27M
1,725.71%6.32M
42.89%-30.61K
Net other financing activities
----
----
----
83.77%-8.56K
----
----
--0
---8.56K
---52.75K
----
Cash from discontinued financing activities
Financing cash flow
208.38%2.86M
184,925.81%6.31M
-29.18%4.44M
23.37%7.73M
1,889.07%547.58K
1,855.95%926.2K
---3.41K
-1.40%6.26M
1,712.15%6.27M
42.89%-30.61K
Net cash flow
Beginning cash position
24.51%6.94M
-67.52%2.9M
-74.69%1.19M
-27.64%4.71M
-57.85%2.89M
-35.80%5.57M
-16.96%8.92M
-27.64%4.71M
-60.58%6.5M
-24.23%6.86M
Current changes in cash
76.56%-628.2K
220.61%4.04M
-59.52%1.71M
-95.55%-3.51M
21.09%-1.7M
-47.52%-2.68M
-62.23%-3.35M
-0.56%4.21M
82.02%-1.8M
15.54%-2.15M
End cash Position
118.17%6.31M
24.51%6.94M
-67.52%2.9M
-74.69%1.19M
-74.69%1.19M
-57.85%2.89M
-35.80%5.57M
-16.96%8.92M
-27.64%4.71M
-27.64%4.71M
Free cash flow
3.37%-3.48M
32.14%-2.27M
-33.24%-2.73M
-39.45%-11.25M
-5.83%-2.25M
-104.45%-3.61M
-62.07%-3.35M
3.08%-2.05M
16.02%-8.07M
14.96%-2.12M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.28%-3.48M32.14%-2.27M-33.24%-2.73M-39.46%-11.25M-5.83%-2.25M-104.58%-3.6M-62.07%-3.35M3.08%-2.05M16.05%-8.06M14.96%-2.12M
Net income from continuing operations -1.53%-3.44M-30.68%-3.93M-3.96%-2.83M-6.55%-11.85M-13.46%-2.73M-62.57%-3.38M-15.22%-3.01M32.21%-2.73M59.45%-11.12M81.52%-2.4M
Depreciation and amortization 48.28%301116.55%301116.55%301252.25%782115.00%301147.56%203--139--139-99.97%222-99.93%140
Other non cash items 10.39%24.32K9.96%23.42K7.34%22.94K-93.74%87.18K7.18%22.48K7.10%22.03K5.53%21.3K-98.39%21.37K256.91%1.39M-63.13%20.98K
Change In working capital 4.79%-375.46K381.91%1.44M-129.98%-146.4K-118.57%-112.4K9,594.72%303.15K-350.42%-394.33K-344.06%-509.57K107.08%488.34K11.33%605.21K-98.55%3.13K
-Change in receivables --024.58%27.77K-24.36%-27.77K-225.00%-39--0--0--22.3K---22.33K-100.02%-12----
-Change in prepaid assets -39.64%-55.61K158.69%615.84K89.32%130K-207.69%-1.03M-108.35%-10.06K-122.97%-39.82K-507.67%-1.05M-83.07%68.67K354.45%956.83K236.11%120.49K
-Change in payables and accrued expense 10.76%-298.02K51.76%815.69K-148.87%-226.3K467.31%1M469.67%335.09K-16,690.35%-333.96K1,936.28%537.5K407.06%463.1K-177.38%-272.72K-128.05%-90.64K
-Change in other current liabilities -6.25%-21.83K-12.99%-22.76K-5.83%-22.31K-6.02%-83.65K-4.32%-21.87K-4.33%-20.55K-4.34%-20.15K-11.40%-21.08K10.28%-78.9K-13.23%-20.97K
-Change in other working capital ----------------------0--22.3K-43,692.16%-22.33K--------
Cash from discontinued investing activities
Operating cash flow 3.28%-3.48M32.14%-2.27M-33.24%-2.73M-39.46%-11.25M-5.83%-2.25M-104.58%-3.6M-62.07%-3.35M3.08%-2.05M16.05%-8.06M14.96%-2.12M
Investing cash flow
Cash flow from continuing investing activities -16.86%-3.24K0-2.78K0
Net PPE purchase and sale -------------16.86%-3.24K--0---------------2.78K--0
Cash from discontinued investing activities
Investing cash flow -------------16.86%-3.24K--0---------------2.78K--0
Financing cash flow
Cash flow from continuing financing activities 208.38%2.86M184,925.81%6.31M-29.18%4.44M23.37%7.73M1,889.07%547.58K1,855.95%926.2K-3.41K-1.40%6.26M1,712.15%6.27M42.89%-30.61K
Net issuance payments of debt -161.10%-3.75K6.54%-1.31K-71.62%-1.54K---5.2K---1.46K---1.44K---1.41K---895--0--0
Net common stock issuance 208.30%2.86M314,406.13%6.31M-29.26%4.44M22.55%7.75M1,893.86%549.05K--927.63K---2.01K-1.25%6.27M1,725.71%6.32M42.89%-30.61K
Net other financing activities ------------83.77%-8.56K----------0---8.56K---52.75K----
Cash from discontinued financing activities
Financing cash flow 208.38%2.86M184,925.81%6.31M-29.18%4.44M23.37%7.73M1,889.07%547.58K1,855.95%926.2K---3.41K-1.40%6.26M1,712.15%6.27M42.89%-30.61K
Net cash flow
Beginning cash position 24.51%6.94M-67.52%2.9M-74.69%1.19M-27.64%4.71M-57.85%2.89M-35.80%5.57M-16.96%8.92M-27.64%4.71M-60.58%6.5M-24.23%6.86M
Current changes in cash 76.56%-628.2K220.61%4.04M-59.52%1.71M-95.55%-3.51M21.09%-1.7M-47.52%-2.68M-62.23%-3.35M-0.56%4.21M82.02%-1.8M15.54%-2.15M
End cash Position 118.17%6.31M24.51%6.94M-67.52%2.9M-74.69%1.19M-74.69%1.19M-57.85%2.89M-35.80%5.57M-16.96%8.92M-27.64%4.71M-27.64%4.71M
Free cash flow 3.37%-3.48M32.14%-2.27M-33.24%-2.73M-39.45%-11.25M-5.83%-2.25M-104.45%-3.61M-62.07%-3.35M3.08%-2.05M16.02%-8.07M14.96%-2.12M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More